FEATURE ARTICLES
Titanium dioxide (TiO2) is used as a food additive and OSD pharmaceutical excipient. In 2020, the European Food Safety Authority noted data gaps regarding particle size, which can affect its toxicological properties, so the European Commission banned it as a food additive. Here's how this could impact pharma.
- FDA Publishes Final Guidance On Reporting Listed Drug Amounts
- 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies
- Managing Supply Chain Risks Using Relational Risk Analysis
- Designing Highly Agile Bio/Pharma Manufacturing Facilities
- A Quality-Led Approach To Drug Production Facility Design
- Quick Takes From Takeda Austria’s Annex 1 Rollout
- Navigating Grades And Sources Of Materials In Drug Manufacturing
PHARMA ONLINE WHITE PAPERS
-
Intro To USP <1062> - What It Is And Why You Should Use It
Knowing how to use USP <1062> helps manufacturers manage the wide variety of factors that can exacerbate production costs, or result in no product at all.
-
Validated LC–MS/MS Method For The Determination Of Copanlisib11/14/2022
Review study findings on a validated LC–MS/MS method for quantifying copanlisib from a mouse dried blood spot and its potential for enabling desirable sensitivity, accuracy, and precision.
-
Extractables And Leachables: Risk Management And Analytical Solutions10/11/2023
Partnering with a CDMO that offers comprehensive and robust E&L studies can help facilitate a smooth product launch by ensuring minimal impact from impurities, all while mitigating risks.
-
Containment Solutions To Help Emerging Biologic Companies Get Products To The Market Faster3/24/2023
Gain solutions on how to set up your small company for long-term success using packaging containment offerings and services to help mitigate risks and speed up your time to market.
-
The Potential Of Networked LC-MS Systems In Analytical Laboratories3/13/2024
Learn how networked Liquid Chromatography-Mass Spectrometry (LC-MS) systems can address the challenges in analytical laboratories, enabling the optimization of data generation and overall efficiency.
-
Considerations And Strategies For Oligonucleotide Manufacturing Scale-Up8/2/2023
To keep up with oligonucleotide demand, manufacturing needs to shift toward larger-scale processes, but this up-scaling process brings challenges that must be addressed.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Solid-State Characterization Of A Small Molecule API
- Establishing A Robust Workflow To Identify High-Performing Clones
- Safer And Faster Conjugation And Purification Of ADCs At 1-20 L Scale
- Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage
- Proper Biological Indicator Placement During Vaporized Hydrogen Peroxide Decontamination Cycles
NEWSLETTER ARCHIVE
- 04.18.24 -- Optimizing Drug Delivery Systems For Complex Biologics
- 04.18.24 -- Designing Highly Agile Bio/Pharma Manufacturing Facilities
- 04.17.24 -- Streamline Oligo Production With A Comprehensive Equipment Range
- 04.17.24 -- Next Generation Isolator Technology
- 04.16.24 -- Novel Approaches In Chromatography Process Development
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
The modern microbiology laboratory is starting to look very different from the laboratory of even 10 years ago. The work will be similar, yet technology will have advanced. Automation, in particular, is taking center stage. Check out the latest e-book from Pharmaceutical Online.
More Content Collections